Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PLXNB2,Plexin-B2,Wald ratio,1,1.1 [1.05-1.15],0.000146974314790658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL18R1,Interleukin-18 receptor 1,Wald ratio,1,1.08 [1.04-1.14],0.000518811465819059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,OGN,Mimecan,Wald ratio,1,0.93 [0.88-0.97],0.00143568516085136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD300E,CMRF35-like molecule 2,Wald ratio,1,0.92 [0.87-0.97],0.00191300526372655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.92 [0.87-0.97],0.00230398536992384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NFASC,Neurofascin,Wald ratio,1,1.08 [1.02-1.14],0.00377194858566189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VEGFD,Vascular endothelial growth factor D,Wald ratio,1,1.08 [1.02-1.15],0.00539900188220724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.93 [0.88-0.98],0.00679091075026516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Wald ratio,1,0.93 [0.88-0.98],0.00806904847649597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LY6D,Lymphocyte antigen 6D,Wald ratio,1,0.93 [0.88-0.98],0.00935025722270186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COLEC12,Collectin-12,Wald ratio,1,0.93 [0.89-0.98],0.0104306584542829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SHISA5,Protein shisa-5,Wald ratio,1,0.93 [0.89-0.99],0.0128651159469219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CTSZ,Cathepsin Z,Wald ratio,1,1.07 [1.01-1.13],0.0139519227079231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCG2,Secretogranin-2,Wald ratio,1,1.07 [1.01-1.13],0.0161427875180516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.06 [1.01-1.11],0.0208811497625394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AOC3,Membrane primary amine oxidase,Wald ratio,1,1.06 [1.01-1.11],0.024427420222652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CLMP,CXADR-like membrane protein,Wald ratio,1,0.94 [0.9-0.99],0.0281950944155444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Wald ratio,1,0.94 [0.89-0.99],0.028784519298957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASE1,Ribonuclease pancreatic,Wald ratio,1,0.94 [0.89-1],0.0323665625966053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GGT5,Glutathione hydrolase 5 proenzyme,Wald ratio,1,1.06 [1-1.12],0.0331038527514078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD79B,B-cell antigen receptor complex-associated protein beta chain,Wald ratio,1,0.94 [0.89-1],0.040074440138146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CDH1,Cadherin-1,Wald ratio,1,1.06 [1-1.12],0.0428563281339188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EPHA2,Ephrin type-A receptor 2,Wald ratio,1,0.95 [0.9-1],0.0462139386721768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SEPTIN8,Septin-8,Wald ratio,1,0.95 [0.9-1],0.0481846357494681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FSTL3,Follistatin-related protein 3,Wald ratio,1,0.95 [0.9-1],0.0495285968100942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD55,Complement decay-accelerating factor,Wald ratio,1,0.95 [0.9-1],0.0556432971439227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD59,CD59 glycoprotein,Wald ratio,1,0.95 [0.9-1],0.0559554684865493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCN3,CCN family member 3,Wald ratio,1,0.95 [0.9-1],0.05862680681124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PRELP,Prolargin,Wald ratio,1,0.95 [0.91-1],0.059325282635766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PIGR,Polymeric immunoglobulin receptor,Wald ratio,1,1.05 [1-1.12],0.0672802541688596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CA12,Carbonic anhydrase 12,Wald ratio,1,0.95 [0.9-1],0.0682001875122696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP6,Insulin-like growth factor-binding protein 6,Wald ratio,1,0.96 [0.91-1],0.068866104270966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RELT,Tumor necrosis factor receptor superfamily member 19L,Wald ratio,1,0.96 [0.91-1],0.0707404065237589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Wald ratio,1,1.05 [1-1.1],0.0734460271235357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GUCA2A,Guanylin,Wald ratio,1,0.95 [0.9-1.01],0.0765202554131686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EPHB6,Ephrin type-B receptor 6,Wald ratio,1,0.95 [0.9-1.01],0.0789058224985119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.95 [0.91-1.01],0.0800572233596281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RBFOX3,RNA binding protein fox-1 homolog 3,Wald ratio,1,0.95 [0.91-1.01],0.0804449124702126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EDA2R,Tumor necrosis factor receptor superfamily member 27,Wald ratio,1,0.96 [0.92-1.01],0.0835580269269502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LGALS4,Galectin-4,Wald ratio,1,1.05 [0.99-1.1],0.0849536127142053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.95 [0.9-1.01],0.0855925643224418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,C7,Complement component C7,Wald ratio,1,1.05 [0.99-1.1],0.0886707285921649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCN5,CCN family member 5,Wald ratio,1,0.96 [0.91-1.01],0.0926368952258718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COL6A3,Collagen alpha-3(VI) chain,Wald ratio,1,0.95 [0.9-1.01],0.0930777654052127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MUC13,Mucin-13,Wald ratio,1,1.05 [0.99-1.11],0.0936707635092787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.95 [0.9-1.01],0.0965030100248424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TAFA5,Chemokine-like protein TAFA-5,Wald ratio,1,0.95 [0.9-1.01],0.0966286400656739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HAVCR1,Hepatitis A virus cellular receptor 1,Wald ratio,1,1.04 [0.99-1.09],0.100222918440195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Wald ratio,1,1.04 [0.99-1.1],0.10457230720221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD300C,CMRF35-like molecule 6,Wald ratio,1,0.96 [0.91-1.01],0.105363058847223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FABP3,"Fatty acid-binding protein, heart",Wald ratio,1,0.96 [0.91-1.01],0.108957624552868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GM2A,Ganglioside GM2 activator,Wald ratio,1,0.96 [0.92-1.01],0.109725329245145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CKB,Creatine kinase B-type,Wald ratio,1,0.96 [0.9-1.01],0.11014029695401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TACSTD2,Tumor-associated calcium signal transducer 2,Wald ratio,1,1.04 [0.99-1.1],0.110964021336668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ANXA5,Annexin A5,Wald ratio,1,0.95 [0.9-1.01],0.113266557583153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CFD,Complement factor D,Wald ratio,1,0.96 [0.91-1.01],0.114861866226759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD300LG,CMRF35-like molecule 9,Wald ratio,1,0.96 [0.91-1.01],0.115554536441858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PRAP1,Proline-rich acidic protein 1,Wald ratio,1,1.04 [0.99-1.1],0.118314644786491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REN,Renin,Wald ratio,1,1.04 [0.99-1.1],0.118669895663145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL10RB,Interleukin-10 receptor subunit beta,Wald ratio,1,0.96 [0.91-1.01],0.119433382579432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Wald ratio,1,0.96 [0.91-1.01],0.119532199885859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DCN,Decorin,Wald ratio,1,0.96 [0.91-1.01],0.122064644315665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL1R1,Interleukin-1 receptor type 1,Wald ratio,1,1.04 [0.99-1.1],0.126058326618993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,INHBB,Inhibin beta B chain,Wald ratio,1,1.04 [0.99-1.1],0.126106028479855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRE5,Adhesion G protein-coupled receptor E5,Wald ratio,1,1.04 [0.99-1.1],0.126779717973618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Wald ratio,1,0.96 [0.91-1.01],0.127567586301797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.96 [0.92-1.01],0.134485920029249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CX3CL1,Fractalkine,Wald ratio,1,0.96 [0.91-1.01],0.13682982639423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IFNGR1,Interferon gamma receptor 1,Wald ratio,1,0.96 [0.91-1.01],0.137792433214562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GPR37,Prosaposin receptor GPR37,Wald ratio,1,0.96 [0.92-1.01],0.140845972700357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LIFR,Leukemia inhibitory factor receptor,Wald ratio,1,1.04 [0.99-1.1],0.142999809036389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASE4,Ribonuclease 4,Wald ratio,1,0.96 [0.91-1.01],0.143776060944484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EDN1,Endothelin-1,Wald ratio,1,0.96 [0.91-1.01],0.145880886280809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Wald ratio,1,0.96 [0.91-1.01],0.146093591012094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Wald ratio,1,0.96 [0.92-1.01],0.149594826279607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.96 [0.91-1.01],0.150946110224511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NCR1,Natural cytotoxicity triggering receptor 1,Wald ratio,1,0.96 [0.91-1.01],0.151012566249796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCARF2,Scavenger receptor class F member 2,Wald ratio,1,0.97 [0.92-1.01],0.154519214614961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,BAMBI,BMP and activin membrane-bound inhibitor homolog,Wald ratio,1,0.96 [0.91-1.02],0.156907665619248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VSIG4,V-set and immunoglobulin domain-containing protein 4,Wald ratio,1,0.96 [0.91-1.02],0.15791793170258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG1B,Lithostathine-1-beta,Wald ratio,1,1.04 [0.98-1.1],0.166553146562078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHRDL1,Chordin-like protein 1,Wald ratio,1,0.97 [0.92-1.02],0.171375913783557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MANSC1,MANSC domain-containing protein 1,Wald ratio,1,0.96 [0.91-1.02],0.171517058939814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD302,CD302 antigen,Wald ratio,1,0.96 [0.91-1.02],0.173354609342483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SMOC2,SPARC-related modular calcium-binding protein 2,Wald ratio,1,0.97 [0.92-1.02],0.175625468942753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Wald ratio,1,0.96 [0.91-1.02],0.17741758018288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG4,Regenerating islet-derived protein 4,Wald ratio,1,1.04 [0.98-1.1],0.185831301738723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Wald ratio,1,0.97 [0.92-1.02],0.192725557604114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD160,CD160 antigen,Wald ratio,1,0.96 [0.91-1.02],0.193133186126435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COL4A1,Collagen alpha-1(IV) chain,Wald ratio,1,1.04 [0.98-1.1],0.199208737674664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KLK11,Kallikrein-11,Wald ratio,1,0.97 [0.91-1.02],0.203669070871287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG1A,Lithostathine-1-alpha,Wald ratio,1,1.04 [0.98-1.09],0.207964843732381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Wald ratio,1,0.97 [0.92-1.02],0.214763597205942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRE2,Adhesion G protein-coupled receptor E2,Wald ratio,1,1.03 [0.98-1.09],0.22024076413316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Wald ratio,1,0.97 [0.91-1.02],0.226796027268574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD14,Monocyte differentiation antigen CD14,Wald ratio,1,0.97 [0.91-1.02],0.230143261529212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCARB2,Lysosome membrane protein 2,Wald ratio,1,0.97 [0.92-1.02],0.233288842542253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VSIG2,V-set and immunoglobulin domain-containing protein 2,Wald ratio,1,1.03 [0.98-1.09],0.243894528990286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Wald ratio,1,1.03 [0.98-1.09],0.246329146427576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NOTCH1,Neurogenic locus notch homolog protein 1,Wald ratio,1,1.03 [0.98-1.09],0.247291086936584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NPY,Pro-neuropeptide Y,Wald ratio,1,1.03 [0.98-1.09],0.251600573335708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CKAP4,Cytoskeleton-associated protein 4,Wald ratio,1,0.97 [0.92-1.02],0.252070642203346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ANGPT2,Angiopoietin-2,Wald ratio,1,1.03 [0.98-1.09],0.255901793382985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NCS1,Neuronal calcium sensor 1,Wald ratio,1,0.97 [0.92-1.02],0.256564948689555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LAYN,Layilin,Wald ratio,1,0.97 [0.92-1.02],0.257443786150752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Wald ratio,1,0.97 [0.93-1.02],0.257879321674801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCL15,C-C motif chemokine 15,Wald ratio,1,1.03 [0.98-1.08],0.262127837817624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NEFL,Neurofilament light polypeptide,Wald ratio,1,1.03 [0.98-1.08],0.272098153339234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TGFBR2,TGF-beta receptor type-2,Wald ratio,1,0.97 [0.92-1.02],0.272604450625708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.03 [0.98-1.09],0.273489711762337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,APOA4,Apolipoprotein A-IV,Wald ratio,1,1.03 [0.97-1.09],0.281661485169232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Wald ratio,1,0.97 [0.92-1.02],0.283403741900539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCGN,Secretagogin,Wald ratio,1,1.03 [0.97-1.09],0.283836132046476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.03 [0.97-1.09],0.291861383449836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VWC2,Brorin,Wald ratio,1,0.97 [0.93-1.02],0.292685083686944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFNA1,Ephrin-A1,Wald ratio,1,0.97 [0.92-1.03],0.29704811768213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LTBR,Tumor necrosis factor receptor superfamily member 3,Wald ratio,1,0.97 [0.92-1.03],0.297103247406307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SORCS2,VPS10 domain-containing receptor SorCS2,Wald ratio,1,0.97 [0.92-1.02],0.297949827120277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CRIM1,Cysteine-rich motor neuron 1 protein,Wald ratio,1,0.97 [0.92-1.03],0.298795197331071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASE6,Ribonuclease K6,Wald ratio,1,0.97 [0.92-1.02],0.299797151487354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRG1,Adhesion G-protein coupled receptor G1,Wald ratio,1,1.03 [0.97-1.09],0.301339653985206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MAMDC2,MAM domain-containing protein 2,Wald ratio,1,1.03 [0.97-1.09],0.311537102016066,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD5,T-cell surface glycoprotein CD5,Wald ratio,1,0.97 [0.92-1.03],0.314414705729166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KLK4,Kallikrein-4,Wald ratio,1,0.98 [0.93-1.02],0.315506507232179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP2,Insulin-like growth factor-binding protein 2,Wald ratio,1,0.97 [0.92-1.03],0.323889929158363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Wald ratio,1,1.03 [0.97-1.08],0.326384201924377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PGF,Placenta growth factor,Wald ratio,1,0.98 [0.93-1.03],0.333196637437615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Wald ratio,1,0.97 [0.92-1.03],0.340320990356112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NECTIN2,Nectin-2,Wald ratio,1,1.03 [0.97-1.09],0.340526257032822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Wald ratio,1,0.98 [0.93-1.03],0.352699223797309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AREG,Amphiregulin,Wald ratio,1,1.03 [0.97-1.09],0.359549735032941,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD4,T-cell surface glycoprotein CD4,Wald ratio,1,0.98 [0.92-1.03],0.3654702052016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Wald ratio,1,1.02 [0.97-1.08],0.365557186289127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SMOC1,SPARC-related modular calcium-binding protein 1,Wald ratio,1,0.98 [0.93-1.03],0.365700630834048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,JAM2,Junctional adhesion molecule B,Wald ratio,1,0.98 [0.92-1.03],0.370504541944058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TFF2,Trefoil factor 2,Wald ratio,1,1.03 [0.97-1.08],0.370652247244761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,XG,Glycoprotein Xg,Wald ratio,1,0.98 [0.94-1.02],0.384109083197528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AMBP,Protein AMBP,Wald ratio,1,1.02 [0.97-1.08],0.384130484417499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCN4,CCN family member 4,Wald ratio,1,0.98 [0.93-1.03],0.392922542436623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CPXM2,Inactive carboxypeptidase-like protein X2,Wald ratio,1,0.98 [0.92-1.03],0.39690393110875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TFF3,Trefoil factor 3,Wald ratio,1,1.02 [0.97-1.08],0.397084191625967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,B2M,Beta-2-microglobulin,Wald ratio,1,0.98 [0.93-1.03],0.402095360979502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.98 [0.92-1.03],0.402914717727195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CXCL16,C-X-C motif chemokine 16,Wald ratio,1,1.02 [0.97-1.08],0.405646399819632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NPDC1,Neural proliferation differentiation and control protein 1,Wald ratio,1,0.98 [0.92-1.03],0.407461816180929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD274,Programmed cell death 1 ligand 1,Wald ratio,1,1.02 [0.97-1.08],0.408152759149386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Wald ratio,1,1.02 [0.97-1.07],0.408596948422818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,B4GALT1,"Beta-1,4-galactosyltransferase 1",Wald ratio,1,0.98 [0.93-1.03],0.411282758148954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Wald ratio,1,1.02 [0.98-1.06],0.411509520523575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD83,CD83 antigen,Wald ratio,1,1.02 [0.97-1.08],0.415748492689214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD27,CD27 antigen,Wald ratio,1,0.98 [0.93-1.03],0.41972068133902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Wald ratio,1,0.98 [0.93-1.03],0.422556956990901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIGLEC1,Sialoadhesin,Wald ratio,1,1.02 [0.97-1.08],0.42694036083425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NPC2,NPC intracellular cholesterol transporter 2,Wald ratio,1,0.98 [0.93-1.03],0.42961299384608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGF1R,Insulin-like growth factor 1 receptor,Wald ratio,1,0.98 [0.93-1.03],0.43151987238003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASET2,Ribonuclease T2,Wald ratio,1,1.02 [0.97-1.08],0.437289636943638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ULBP2,UL16-binding protein 2,Wald ratio,1,0.98 [0.93-1.03],0.439248232396263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CDH3,Cadherin-3,Wald ratio,1,0.98 [0.92-1.03],0.442157985198159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TFF1,Trefoil factor 1,Wald ratio,1,1.02 [0.97-1.08],0.459460691329319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,UMOD,Uromodulin,Wald ratio,1,1.02 [0.97-1.06],0.462852472775566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MMP7,Matrilysin,Wald ratio,1,1.02 [0.97-1.08],0.463466060244724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Wald ratio,1,1.02 [0.97-1.08],0.464629004826509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HAVCR2,Hepatitis A virus cellular receptor 2,Wald ratio,1,0.98 [0.93-1.04],0.474861227520038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LAG3,Lymphocyte activation gene 3 protein,Wald ratio,1,1.02 [0.97-1.08],0.477687333022172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.98 [0.93-1.04],0.480715675998505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Wald ratio,1,0.98 [0.94-1.03],0.484139892008218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DSC2,Desmocollin-2,Wald ratio,1,0.98 [0.93-1.04],0.488484511155235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPON1,Spondin-1,Wald ratio,1,1.02 [0.97-1.07],0.495180003342577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CST3,Cystatin-C,Wald ratio,1,0.98 [0.93-1.03],0.502701532488631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RTN4R,Reticulon-4 receptor,Wald ratio,1,1.02 [0.97-1.07],0.506661015614696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ATRAID,All-trans retinoic acid-induced differentiation factor,Wald ratio,1,0.98 [0.93-1.04],0.509085640560944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCL14,C-C motif chemokine 14,Wald ratio,1,0.98 [0.93-1.04],0.511158186183344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RBP2,Retinol-binding protein 2,Wald ratio,1,0.98 [0.93-1.04],0.513800340124043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NECTIN4,Nectin-4,Wald ratio,1,0.98 [0.93-1.04],0.514060313513774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PRSS8,Prostasin,Wald ratio,1,1.02 [0.97-1.07],0.519202318683386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,WFDC2,WAP four-disulfide core domain protein 2,Wald ratio,1,1.02 [0.96-1.07],0.520050237286033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.02 [0.97-1.07],0.523434485620916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FAM3C,Protein FAM3C,Wald ratio,1,0.98 [0.93-1.04],0.526256723546851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPINT2,Kunitz-type protease inhibitor 2,Wald ratio,1,0.98 [0.93-1.04],0.536936054195793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD276,CD276 antigen,Wald ratio,1,0.99 [0.94-1.03],0.545725516631634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.02 [0.96-1.07],0.545988257901213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,WNT9A,Protein Wnt-9a,Wald ratio,1,0.98 [0.93-1.04],0.550767161602227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DDR1,Epithelial discoidin domain-containing receptor 1,Wald ratio,1,1.02 [0.96-1.07],0.555316655078011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FAM3B,Protein FAM3B,Wald ratio,1,1.02 [0.96-1.07],0.556281210104158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LGALS9,Galectin-9,Wald ratio,1,0.98 [0.94-1.04],0.560459408625679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ESAM,Endothelial cell-selective adhesion molecule,Wald ratio,1,0.98 [0.93-1.04],0.567343046236985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD93,Complement component C1q receptor,Wald ratio,1,0.98 [0.93-1.04],0.571152539411282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHI3L1,Chitinase-3-like protein 1,Wald ratio,1,1.01 [0.97-1.07],0.573536443376666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PDCD1LG2,Programmed cell death 1 ligand 2,Wald ratio,1,0.99 [0.94-1.03],0.574441508466585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADM,Pro-adrenomedullin,Wald ratio,1,1.01 [0.96-1.07],0.586987722099491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AGRN,Agrin,Wald ratio,1,0.99 [0.93-1.04],0.594235983167536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,BSG,Basigin,Wald ratio,1,0.99 [0.93-1.04],0.604747873164728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HYAL1,Hyaluronidase-1,Wald ratio,1,1.01 [0.96-1.07],0.606184844269224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PTGDS,Prostaglandin-H2 D-isomerase,Wald ratio,1,0.99 [0.93-1.04],0.60669553044058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Wald ratio,1,0.99 [0.94-1.04],0.609537829590056,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FGF23,Fibroblast growth factor 23,Wald ratio,1,1.01 [0.96-1.07],0.612125195771039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DKK4,Dickkopf-related protein 4,Wald ratio,1,0.99 [0.93-1.04],0.617146929262604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PI3,Elafin,Wald ratio,1,1.01 [0.96-1.07],0.621424481748748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRB3,Adhesion G protein-coupled receptor B3,Wald ratio,1,1.01 [0.97-1.05],0.625377820908355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.99 [0.93-1.04],0.636027618186932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RSPO3,R-spondin-3,Wald ratio,1,0.99 [0.94-1.04],0.636741446296303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FOLR1,Folate receptor alpha,Wald ratio,1,1.01 [0.96-1.07],0.640577390893593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD48,CD48 antigen,Wald ratio,1,0.99 [0.94-1.04],0.643835992618792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ASGR2,Asialoglycoprotein receptor 2,Wald ratio,1,0.99 [0.94-1.04],0.650043706428492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TIMP1,Metalloproteinase inhibitor 1,Wald ratio,1,0.99 [0.93-1.04],0.654789489354466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.99 [0.93-1.04],0.658172455725708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNF149,E3 ubiquitin-protein ligase RNF149,Wald ratio,1,0.99 [0.93-1.04],0.658438375220976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Wald ratio,1,0.99 [0.93-1.04],0.658612230366926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.99 [0.94-1.04],0.663550372103525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.99 [0.93-1.04],0.663778519266914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ACVRL1,Serine/threonine-protein kinase receptor R3,Wald ratio,1,0.99 [0.94-1.04],0.667592427111888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL2RA,Interleukin-2 receptor subunit alpha,Wald ratio,1,0.99 [0.93-1.05],0.670723883531803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NELL1,Protein kinase C-binding protein NELL1,Wald ratio,1,1.01 [0.96-1.07],0.685324107409702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Wald ratio,1,1.01 [0.96-1.06],0.692605142942832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.99 [0.94-1.04],0.708085715265391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,QPCT,Glutaminyl-peptide cyclotransferase,Wald ratio,1,0.99 [0.94-1.05],0.721525512865793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPINK4,Serine protease inhibitor Kazal-type 4,Wald ratio,1,1.01 [0.96-1.06],0.721540475775375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Wald ratio,1,0.99 [0.94-1.04],0.734620964978826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PALM2,Paralemmin-2,Wald ratio,1,0.99 [0.94-1.05],0.736908929599785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HYOU1,Hypoxia up-regulated protein 1,Wald ratio,1,0.99 [0.94-1.05],0.74620840411231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADA2,Adenosine deaminase 2,Wald ratio,1,1.01 [0.96-1.07],0.751860395673099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PDGFRA,Platelet-derived growth factor receptor alpha,Wald ratio,1,1.01 [0.96-1.07],0.755878979565893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PLAUR,Urokinase plasminogen activator surface receptor,Wald ratio,1,1.01 [0.95-1.07],0.756804159733607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL18BP,Interleukin-18-binding protein,Wald ratio,1,0.99 [0.94-1.05],0.757944660104196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FGF5,Fibroblast growth factor 5,Wald ratio,1,1.01 [0.96-1.06],0.765535655875103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MDK,Midkine,Wald ratio,1,0.99 [0.94-1.05],0.794187654303018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DLL1,Delta-like protein 1,Wald ratio,1,0.99 [0.94-1.05],0.801047691951035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG3A,Regenerating islet-derived protein 3-alpha,Wald ratio,1,1.01 [0.95-1.06],0.80634844791883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CGREF1,Cell growth regulator with EF hand domain protein 1,Wald ratio,1,0.99 [0.95-1.04],0.817231170425338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPON2,Spondin-2,Wald ratio,1,1.01 [0.95-1.06],0.817355225735974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Wald ratio,1,0.99 [0.94-1.05],0.8200478239217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.99 [0.94-1.05],0.826130685235405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,BTN3A2,Butyrophilin subfamily 3 member A2,Wald ratio,1,1.01 [0.96-1.06],0.826805268247213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SNCG,Gamma-synuclein,Wald ratio,1,1.01 [0.95-1.06],0.832846610286458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GFRA1,GDNF family receptor alpha-1,Wald ratio,1,0.99 [0.94-1.05],0.842619223936138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,STC1,Stanniocalcin-1,Wald ratio,1,1.01 [0.95-1.06],0.847431048225067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHGB,Secretogranin-1,Wald ratio,1,1 [0.95-1.05],0.849402053335634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FABP1,"Fatty acid-binding protein, liver",Wald ratio,1,0.99 [0.94-1.05],0.854602083012089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPINK1,Serine protease inhibitor Kazal-type 1,Wald ratio,1,1 [0.95-1.06],0.86193493372706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Wald ratio,1,1 [0.95-1.06],0.870027492083071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FGFR2,Fibroblast growth factor receptor 2,Wald ratio,1,1 [0.94-1.05],0.871455432479467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP7,Insulin-like growth factor-binding protein 7,Wald ratio,1,1 [0.95-1.06],0.88015987297434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LTBP2,Latent-transforming growth factor beta-binding protein 2,Wald ratio,1,1 [0.96-1.05],0.885225581244825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VCAM1,Vascular cell adhesion protein 1,Wald ratio,1,1 [0.94-1.05],0.892408286316711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SFRP1,Secreted frizzled-related protein 1,Wald ratio,1,1 [0.95-1.06],0.899483784653444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PSAP,Prosaposin,Wald ratio,1,1 [0.95-1.06],0.907931395835242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD46,Membrane cofactor protein,Wald ratio,1,1 [0.95-1.06],0.909791245768669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL4R,Interleukin-4 receptor subunit alpha,Wald ratio,1,1 [0.95-1.06],0.911604445450567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ASGR1,Asialoglycoprotein receptor 1,Wald ratio,1,1 [0.95-1.06],0.916899789069044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFNA4,Ephrin-A4,Wald ratio,1,1 [0.94-1.06],0.933192810516875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Wald ratio,1,1 [0.94-1.05],0.955158075666094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1 [0.94-1.06],0.977787350159232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHGA,Chromogranin-A,Wald ratio,1,1 [0.95-1.06],0.978012971611712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COL18A1,Collagen alpha-1(XVIII) chain,Wald ratio,1,1 [0.95-1.06],0.984805918832413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIRPB1,Signal-regulatory protein beta-1,Wald ratio,1,1 [0.96-1.05],0.986163510703589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CSF1,Macrophage colony-stimulating factor 1,Wald ratio,1,1 [0.95-1.06],0.996449210960912,trans
